Insiders · Profile

Chesworth Richard

Chief Scientific Officer at Kymera Therapeutics. Filing since 17 Aug 2021. CIK 0001821188

Company
Date
Role
Action
Shares
Amount
Of holding
27 Aug 2021
Chief Scientific Officer
Sold, plan not stated
33,779
$2.03M
100%
17 Aug 2021
Chief Scientific Officer
Sold, plan not stated
54,000
$2.72M
100%
2 decisions on file.